Platelet transfusion guidelines tell clinicians when a low platelet count is dangerous enough to justify giving donor platelets, and how many to give. The core rule is simple: for a stable patient whose bone marrow is not making enough platelets, a preventive transfusion is usually given when the count falls below 10 x 10⁹/L, with higher thresholds for procedures, surgery, and active bleeding. The details, and the exceptions, are where good practice lives.
In haematology, few decisions are made as often as this one. Below I walk through the thresholds, the situations where transfusion can do harm, and what to do when transfused platelets simply do not work.
What Is a Platelet Transfusion?
A platelet transfusion delivers concentrated donor platelets into a patient’s bloodstream to prevent or stop bleeding. Platelets are small cell fragments without a nucleus, shed by large cells called megakaryocytes in the bone marrow. They form the first plug at the site of a damaged blood vessel, a process called primary hemostasis.
A normal platelet count is roughly 150 to 400 x 10⁹/L, and platelets survive in the circulation for about 7 to 10 days. When the count falls below the normal range, the condition is called thrombocytopenia. Mild thrombocytopenia rarely causes bleeding; the risk rises steeply only when counts become very low.
Platelets for transfusion come in two main forms. An apheresis unit is collected from a single donor using a machine that returns the other blood components. A pooled unit combines platelets separated from several whole-blood donations. Either one typically makes up a standard adult dose.
Prophylactic vs. Therapeutic Transfusion
Guidelines separate transfusions into two broad groups. Prophylactic transfusions are given to prevent bleeding in a patient who is not bleeding now. Therapeutic transfusions are given to treat bleeding that is already happening.
Prophylaxis makes most sense in hypoproliferative thrombocytopenia, where the marrow is failing to produce platelets. Examples include patients receiving intensive chemotherapy, patients after stem cell transplantation, and people with aplastic anemia or acute leukemia. The goal is to keep the count above the level at which spontaneous bleeding becomes likely, not to normalize it.
Therapeutic transfusion is guided more by the clinical picture than by a single number. A patient with heavy bleeding and a moderately low count may need platelets quickly, while a patient with a very low count and only a few skin spots may not. Our longer piece on platelet transfusion in hematologic care covers how these decisions play out on the ward.
Platelet Count Thresholds at a Glance
The thresholds below reflect widely accepted guideline cut-offs for adults. Local protocols vary, and clinical judgment always overrides a table, but these numbers are the common starting points.
| Clinical situation | Usual transfusion threshold (x 10⁹/L) |
|---|---|
| Stable patient with marrow failure (chemotherapy, transplant) | Below 10 |
| Fever, infection, or other added bleeding risk | Below 20 |
| Central venous catheter insertion | Below 20 |
| Lumbar puncture | Below 40 to 50 |
| Major non-neurological surgery | Below 50 |
| Active significant bleeding, trauma, or bleeding with DIC | Keep above 50 |
| Neurosurgery, eye surgery, or bleeding into the brain | Keep above 100 |
For patients whose platelets work poorly despite a normal count, such as those taking antiplatelet drugs or undergoing cardiac bypass, the decision rests on bleeding rather than the number.
When Platelet Transfusions Can Do Harm
Not every low count should be treated with donor platelets. In several conditions, transfusion adds little or is actively risky.
- Immune thrombocytopenia (ITP): antibodies destroy platelets, including transfused ones, within hours. Transfusion is reserved for life-threatening bleeding, usually alongside immune treatment. Our article on ITP and the role of platelet transfusion explains this in depth.
- Thrombotic thrombocytopenic purpura (TTP): platelets are consumed in small clots, and adding more may worsen clotting. Transfusion is generally avoided unless bleeding is life-threatening.
- Heparin-induced thrombocytopenia (HIT): the main danger is clotting, not bleeding, so prophylactic platelets are not given.
This is why the cause of severe thrombocytopenia must be clear before a transfusion is ordered. A blood film, clotting tests, and sometimes a bone marrow examination help separate low production from increased destruction.
Dosing, Compatibility, and Risks
A single adult dose is usually enough for prophylaxis; giving larger doses does not reliably reduce bleeding. A post-transfusion count, taken 10 to 60 minutes after the transfusion ends, shows whether the platelets are circulating as expected.
ABO-compatible platelets are preferred when available because they tend to give a better increment. Platelet units carry a small amount of plasma and red cells, so women of childbearing potential who are RhD-negative may receive anti-D immunoglobulin if they get RhD-positive platelets. Irradiated platelets are used for patients at risk of transfusion-associated graft-versus-host disease, such as stem cell transplant recipients.
Platelets are stored at room temperature with gentle agitation, which gives them a short shelf life of about 5 days in standard practice. Room-temperature storage also makes them the blood component most prone to bacterial contamination. Other recognized risks include:
- Febrile and allergic reactions, which are the most common and usually mild
- Transfusion-related acute lung injury (TRALI) and circulatory overload
- Development of antibodies against donor platelets (alloimmunization)
More on the practical side of administration is covered in our guide to platelet transfusions in hematology.
Platelet Refractoriness
Platelet refractoriness means the count fails to rise as expected after repeated transfusions. It is usually confirmed when two consecutive, ABO-compatible, fresh transfusions give a poor one-hour increment.
The causes fall into two groups. Non-immune causes are more common and include fever, infection, sepsis, an enlarged spleen, bleeding, DIC, and certain drugs. Immune causes are mainly antibodies against HLA antigens on donor platelets, and less often against human platelet antigens (HPA).
When immune refractoriness is suspected, the patient is tested for HLA antibodies. Management then shifts to HLA-matched platelets, antigen-negative platelets chosen to avoid the patient’s antibodies, or crossmatched platelets. Leukoreduction of blood products lowers the chance of HLA alloimmunization in the first place.
Key Takeaways
- Prophylactic platelet transfusion in stable marrow failure is usually triggered by a count below 10 x 10⁹/L.
- Higher thresholds apply for procedures, surgery, active bleeding, and the brain or eye.
- ITP, TTP, and HIT are situations where platelets are avoided or reserved for life-threatening bleeding.
- One adult dose is standard; check a post-transfusion count to confirm a response.
- Poor increments call for a search for non-immune causes first, then HLA antibody testing.
Frequently Asked Questions
What platelet count needs a transfusion?
For a stable patient whose marrow is not producing platelets, the usual trigger is a count below 10 x 10⁹/L. The threshold is raised to 20 with fever or infection, 50 for most major surgery or active bleeding, and 100 for neurosurgery. Your care team adjusts these for your situation.
How long do transfused platelets last?
Donor platelets survive for several days at most after transfusion, often less in patients who are ill, feverish, or bleeding. That is why patients with ongoing marrow failure may need transfusions every few days.
Why are platelets not given for ITP?
In ITP, the immune system destroys platelets quickly, so donor platelets are cleared almost as fast as they arrive. Transfusion is kept for emergencies such as bleeding into the brain, where even a short rise can help while other treatments take effect.
Do platelets need to match my blood type?
ABO-matched platelets are preferred because they usually give a better rise in count, but mismatched units can be given when matched ones are not available. RhD type matters mainly for women who may become pregnant in the future.
